オミックスベースの臨床試験の世界市場規模調査、フェーズ別(フェーズI、フェーズII、フェーズIII、フェーズIV)、試験デザイン別(介入試験、観察試験、拡大アクセス試験)、適応症別(腫瘍、循環器、呼吸器、皮膚、中枢神経、免疫、遺伝子疾患(希少疾患含む)、その他(眼科、耳疾患含む))と地域予測2022-2028年Global Omics-Based Clinical Trials Market Size study, by Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Studies, Observational Studies, Expanded Access Studies), By Indication (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases (includes the rare diseases), Others (includes ophthalmic, ear diseases)) and Regional Forecasts 2022-2028 オミックスベースの臨床試験の世界市場は、2021年に約244億米ドルと評価され、予測期間2022-2028年には7.4%以上の健全な成長率で成長すると予想されています。オミックスベースの臨床試験は、ゲノミクス、メタボ... もっと見る
サマリーオミックスベースの臨床試験の世界市場は、2021年に約244億米ドルと評価され、予測期間2022-2028年には7.4%以上の健全な成長率で成長すると予想されています。オミックスベースの臨床試験は、ゲノミクス、メタボロミクス、エピゲノミクス、プロテオミクスなどに関連した患者の臨床分析に使用されます。慢性疾患の増加により、予測期間中、オミックスベースの臨床試験の採用が進んでいます。例えば2021年の米国疾病管理予防センターによると、慢性疾患の患者数と死亡者数は急速に増加しています。糖尿病の患者数は2億8,500万人で、これは世界の総成人人口の約6.4%に相当します。製薬会社による投資の増加は、オミックスベースの臨床試験市場の成長を後押ししています。また、臨床試験におけるオミックスアプローチの需要の増加により、オミックスベースの臨床試験の採用や需要は予測期間中に市場成長を高めると思われます。しかし、臨床試験のコスト上昇は、2022-2028年の予測期間における市場成長の妨げとなる。オミックスベースの臨床試験の世界市場分析で考慮した地理的地域は、アジア太平洋、北米、ヨーロッパ、ラテンアメリカ、その他の地域です。北米は、慢性疾患の症例数の増加、主要プレイヤーの存在、医療の進歩に向けた投資の増加により、巨大な市場シェアの点で世界の主要地域となっています。一方、アジア太平洋地域は、2022年から2028年の間に最大の成長率を達成すると推定されています。臨床試験における研究開発の増加や、ヘルスケア部門に対する政府支出の増加といった要因が、アジア太平洋地域のオミックスベースの臨床試験市場に有益な成長予測を生み出すと考えられます。 本レポートに含まれる主な市場関係者は以下の通りです。 パレクセル・インターナショナル・コーポレーション ファーマシューティカル・プロダクト・ディベロップメント (PPD) チャールズリバーラボラトリー ICON plc SGS SA イーライリリー・アンド・カンパニー ファイザー株式会社 コバンス社 ノボノルディスク リーバス・バイオ 本調査の目的は、近年における様々なセグメント&国の市場規模を定義し、今後8年間の値を予測することです。本レポートは、調査対象となる各地域および各国における産業の質的および量的な側面を取り込むよう設計されています。さらに、市場の将来的な成長を規定する駆動因子や課題などの重要な側面に関する詳細な情報も提供しています。さらに、本レポートでは、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場で利用可能な機会も組み込まなければなりません。市場の詳細なセグメントとサブセグメントを以下に説明します。 フェーズ別 フェーズI フェーズII フェーズIII フェーズIV 研究デザイン別 介入研究 観察研究(Observational Studies エクスパンデッドアクセススタディ 適応症別 オンコロジー 循環器領域 呼吸器領域 皮膚疾患 中枢神経系 免疫学 遺伝性疾患(希少疾病を含む) その他(眼科疾患、耳鼻咽喉科疾患など) 地域別 北米 米国 カナダ 欧州 英国 ドイツ フランス スペイン イタリア ROE アジア太平洋地域 中国 インド 日本 オーストラリア 韓国 ロアパック ラテンアメリカ ブラジル メキシコ その他の地域 さらに、調査のために考慮した年は以下の通りです。 過去年 - 2018年,2019年,2020年 基準年 - 2021年 予測期間 - 2022年~2028年 市場調査における世界のオミックスベースの臨床試験市場の対象読者 主要なコンサルティング会社およびアドバイザー 大企業、中堅企業、中小企業 ベンチャーキャピタル 付加価値再販業者(VAR) サードパーティー・ナレッジ・プロバイダー 投資銀行家 投資家 目次Chapter 1. Executive Summary1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion) 1.2.1. Omics-Based Clinical Trials Market, by Region, 2020-2028(USD Billion) 1.2.2. Omics-Based Clinical Trials Market, by Phase, 2020-2028(USD Billion) 1.2.3. Omics-Based Clinical Trials Market, by Study Design, 2020-2028(USD Billion) 1.2.4. Omics-Based Clinical Trials Market, by Indication, 2020-2028(USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Omics-Based Clinical Trials Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Omics-Based Clinical Trials Market Dynamics 3.1. Omics-Based Clinical Trials Market Impact Analysis (2020-2028) 3.1.1. Market Drivers 3.1.1.1. Growing incidences of chronic diseases 3.1.1.2. Increasing investment by pharmaceutical companies 3.1.2. Market Challenges 3.1.2.1. Higher cost of clinical trials 3.1.3. Market Opportunities 3.1.3.1. Increasing demand for omics approaches for clinical trials Chapter 4. Global Omics-Based Clinical Trials Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion 4.5. Top investment opportunity 4.6. Top winning strategies Chapter 5. Risk Assessment: COVID-19 Impact 5.1.1. Assessment of the overall impact of COVID-19 on the industry 5.1.2. Pre COVID-19 and post COVID-19 market scenario Chapter 6. Global Omics-Based Clinical Trials Market, by Phase 6.1. Market Snapshot 6.2. Global Omics-Based Clinical Trials Market by Phase, Performance - Potential Analysis 6.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Phase, 2019-2028 (USD Billion) 6.4. Omics-Based Clinical Trials Market, Sub Segment Analysis 6.4.1. Phase I 6.4.2. Phase II 6.4.3. Phase III 6.4.4. Phase IV Chapter 7. Global Omics-Based Clinical Trials Market, by Study Design 7.1. Market Snapshot 7.2. Global Omics-Based Clinical Trials Market by Study Design, Performance - Potential Analysis 7.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Study Design, 2019-2028 (USD Billion) 7.4. Omics-Based Clinical Trials Market, Sub Segment Analysis 7.4.1. Interventional Studies 7.4.2. Observational Studies 7.4.3. Expanded Access Studies Chapter 8. Global Omics-Based Clinical Trials Market, by Indication 8.1. Market Snapshot 8.2. Global Omics-Based Clinical Trials Market by Indication, Performance - Potential Analysis 8.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Indication, 2019-2028 (USD Billion) 8.4. Omics-Based Clinical Trials Market, Sub Segment Analysis 8.4.1. Oncology 8.4.2. Cardiology 8.4.3. Respiratory Diseases 8.4.4. Skin Diseases 8.4.5. CNS Diseases 8.4.6. Immunology 8.4.7. Genetic Diseases (includes the rare diseases) 8.4.8. Others (includes ophthalmic, ear diseases, etc) Chapter 9. Global Omics-Based Clinical Trials Market, Regional Analysis 9.1. Omics-Based Clinical Trials Market, Regional Market Snapshot 9.2. North America Omics-Based Clinical Trials Market 9.2.1. U.S. Omics-Based Clinical Trials Market 9.2.1.1. Phase breakdown estimates & forecasts, 2019-2028 9.2.1.2. Study Design breakdown estimates & forecasts, 2019-2028 9.2.1.3. Indication breakdown estimates & forecasts, 2019-2028 9.2.2. Canada Omics-Based Clinical Trials Market 9.3. Europe Omics-Based Clinical Trials Market Snapshot 9.3.1. U.K. Omics-Based Clinical Trials Market 9.3.2. Germany Omics-Based Clinical Trials Market 9.3.3. France Omics-Based Clinical Trials Market 9.3.4. Spain Omics-Based Clinical Trials Market 9.3.5. Italy Omics-Based Clinical Trials Market 9.3.6. Rest of Europe Omics-Based Clinical Trials Market 9.4. Asia-Pacific Omics-Based Clinical Trials Market Snapshot 9.4.1. China Omics-Based Clinical Trials Market 9.4.2. India Omics-Based Clinical Trials Market 9.4.3. Japan Omics-Based Clinical Trials Market 9.4.4. Australia Omics-Based Clinical Trials Market 9.4.5. South Korea Omics-Based Clinical Trials Market 9.4.6. Rest of Asia Pacific Omics-Based Clinical Trials Market 9.5. Latin America Omics-Based Clinical Trials Market Snapshot 9.5.1. Brazil Omics-Based Clinical Trials Market 9.5.2. Mexico Omics-Based Clinical Trials Market 9.6. Rest of The World Omics-Based Clinical Trials Market Chapter 10. Competitive Intelligence 10.1. Top Market Strategies 10.2. Company Profiles 10.2.1. Parexel International Corporation 10.2.1.1. Key Information 10.2.1.2. Overview 10.2.1.3. Financial (Subject to Data Availability) 10.2.1.4. Product Summary 10.2.1.5. Recent Developments 10.2.2. Pharmaceutical Product Development (PPD) 10.2.3. Charles River Laboratory 10.2.4. ICON plc 10.2.5. SGS SA 10.2.6. Eli Lilly and Company 10.2.7. Pfizer Inc. 10.2.8. Covance Inc. 10.2.9. Novo Nordisk 10.2.10. Rebus Bio Chapter 11. Research Process 11.1. Research Process 11.1.1. Data Mining 11.1.2. Analysis 11.1.3. Market Estimation 11.1.4. Validation 11.1.5. Publishing 11.2. Research Attributes 11.3. Research Assumption List of Tables TABLE 1. Global Omics-Based Clinical Trials market, report scope TABLE 2. Global Omics-Based Clinical Trials market estimates & forecasts by Region 2019-2028 (USD Billion) TABLE 3. Global Omics-Based Clinical Trials market estimates & forecasts by Phase 2019-2028 (USD Billion) TABLE 4. Global Omics-Based Clinical Trials market estimates & forecasts by Study Design 2019-2028 (USD Billion) TABLE 5. Global Omics-Based Clinical Trials market estimates & forecasts by Indication 2019-2028 (USD Billion) TABLE 6. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 7. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 8. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 9. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 10. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 11. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 12. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 13. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 14. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 15. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 16. U.S. Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 17. U.S. Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 18. U.S. Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 19. Canada Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 20. Canada Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 21. Canada Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 22. UK Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 23. UK Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 24. UK Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 25. Germany Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 26. Germany Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 27. Germany Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 28. RoE Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 29. RoE Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 30. RoE Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 31. China Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 32. China Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 33. China Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 34. India Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 35. India Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 36. India Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 37. Japan Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 38. Japan Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 39. Japan Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 40. RoAPAC Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 41. RoAPAC Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 42. RoAPAC Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 43. Brazil Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 44. Brazil Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 45. Brazil Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 46. Mexico Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 47. Mexico Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 48. Mexico Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 49. RoLA Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 50. RoLA Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 51. RoLA Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 52. Row Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 53. Row Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 54. Row Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 55. List of secondary sources, used in the study of global Omics-Based Clinical Trials market TABLE 56. List of primary sources, used in the study of global Omics-Based Clinical Trials market TABLE 57. Years considered for the study TABLE 58. Exchange rates considered
SummaryGlobal Omics-Based Clinical Trials Market is valued at approximately USD 24.4 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4 % over the forecast period 2022-2028. Omics-Based Clinical Trials are used for the clinical analysis of patients related to genomics, metabolomics epigenomics, proteomics etc. The growing incidences of chronic diseases have led to the adoption of Omics-Based Clinical Trials across the forecast period. For Instance: According to the Centers for Disease Control and Prevention in 2021, the number of cases and deaths by chronic diseases is increasing rapidly. The diabetic cases with illness have affected 285 million people which is equivalent to about 6.4 % of the total adult population globally. Increasing investment by pharmaceutical companies pushes the market growth of omics-based clinical trials. Also, with the increasing demand for omics approaches for clinical trials, the adoption & demand for Omics-Based Clinical Trials is likely to increase the market growth during the forecast period. However, higher costs of clinical trials impede the growth of the market over the forecast period of 2022-2028. Table of ContentsChapter 1. Executive Summary1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion) 1.2.1. Omics-Based Clinical Trials Market, by Region, 2020-2028(USD Billion) 1.2.2. Omics-Based Clinical Trials Market, by Phase, 2020-2028(USD Billion) 1.2.3. Omics-Based Clinical Trials Market, by Study Design, 2020-2028(USD Billion) 1.2.4. Omics-Based Clinical Trials Market, by Indication, 2020-2028(USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Omics-Based Clinical Trials Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Omics-Based Clinical Trials Market Dynamics 3.1. Omics-Based Clinical Trials Market Impact Analysis (2020-2028) 3.1.1. Market Drivers 3.1.1.1. Growing incidences of chronic diseases 3.1.1.2. Increasing investment by pharmaceutical companies 3.1.2. Market Challenges 3.1.2.1. Higher cost of clinical trials 3.1.3. Market Opportunities 3.1.3.1. Increasing demand for omics approaches for clinical trials Chapter 4. Global Omics-Based Clinical Trials Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion 4.5. Top investment opportunity 4.6. Top winning strategies Chapter 5. Risk Assessment: COVID-19 Impact 5.1.1. Assessment of the overall impact of COVID-19 on the industry 5.1.2. Pre COVID-19 and post COVID-19 market scenario Chapter 6. Global Omics-Based Clinical Trials Market, by Phase 6.1. Market Snapshot 6.2. Global Omics-Based Clinical Trials Market by Phase, Performance - Potential Analysis 6.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Phase, 2019-2028 (USD Billion) 6.4. Omics-Based Clinical Trials Market, Sub Segment Analysis 6.4.1. Phase I 6.4.2. Phase II 6.4.3. Phase III 6.4.4. Phase IV Chapter 7. Global Omics-Based Clinical Trials Market, by Study Design 7.1. Market Snapshot 7.2. Global Omics-Based Clinical Trials Market by Study Design, Performance - Potential Analysis 7.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Study Design, 2019-2028 (USD Billion) 7.4. Omics-Based Clinical Trials Market, Sub Segment Analysis 7.4.1. Interventional Studies 7.4.2. Observational Studies 7.4.3. Expanded Access Studies Chapter 8. Global Omics-Based Clinical Trials Market, by Indication 8.1. Market Snapshot 8.2. Global Omics-Based Clinical Trials Market by Indication, Performance - Potential Analysis 8.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Indication, 2019-2028 (USD Billion) 8.4. Omics-Based Clinical Trials Market, Sub Segment Analysis 8.4.1. Oncology 8.4.2. Cardiology 8.4.3. Respiratory Diseases 8.4.4. Skin Diseases 8.4.5. CNS Diseases 8.4.6. Immunology 8.4.7. Genetic Diseases (includes the rare diseases) 8.4.8. Others (includes ophthalmic, ear diseases, etc) Chapter 9. Global Omics-Based Clinical Trials Market, Regional Analysis 9.1. Omics-Based Clinical Trials Market, Regional Market Snapshot 9.2. North America Omics-Based Clinical Trials Market 9.2.1. U.S. Omics-Based Clinical Trials Market 9.2.1.1. Phase breakdown estimates & forecasts, 2019-2028 9.2.1.2. Study Design breakdown estimates & forecasts, 2019-2028 9.2.1.3. Indication breakdown estimates & forecasts, 2019-2028 9.2.2. Canada Omics-Based Clinical Trials Market 9.3. Europe Omics-Based Clinical Trials Market Snapshot 9.3.1. U.K. Omics-Based Clinical Trials Market 9.3.2. Germany Omics-Based Clinical Trials Market 9.3.3. France Omics-Based Clinical Trials Market 9.3.4. Spain Omics-Based Clinical Trials Market 9.3.5. Italy Omics-Based Clinical Trials Market 9.3.6. Rest of Europe Omics-Based Clinical Trials Market 9.4. Asia-Pacific Omics-Based Clinical Trials Market Snapshot 9.4.1. China Omics-Based Clinical Trials Market 9.4.2. India Omics-Based Clinical Trials Market 9.4.3. Japan Omics-Based Clinical Trials Market 9.4.4. Australia Omics-Based Clinical Trials Market 9.4.5. South Korea Omics-Based Clinical Trials Market 9.4.6. Rest of Asia Pacific Omics-Based Clinical Trials Market 9.5. Latin America Omics-Based Clinical Trials Market Snapshot 9.5.1. Brazil Omics-Based Clinical Trials Market 9.5.2. Mexico Omics-Based Clinical Trials Market 9.6. Rest of The World Omics-Based Clinical Trials Market Chapter 10. Competitive Intelligence 10.1. Top Market Strategies 10.2. Company Profiles 10.2.1. Parexel International Corporation 10.2.1.1. Key Information 10.2.1.2. Overview 10.2.1.3. Financial (Subject to Data Availability) 10.2.1.4. Product Summary 10.2.1.5. Recent Developments 10.2.2. Pharmaceutical Product Development (PPD) 10.2.3. Charles River Laboratory 10.2.4. ICON plc 10.2.5. SGS SA 10.2.6. Eli Lilly and Company 10.2.7. Pfizer Inc. 10.2.8. Covance Inc. 10.2.9. Novo Nordisk 10.2.10. Rebus Bio Chapter 11. Research Process 11.1. Research Process 11.1.1. Data Mining 11.1.2. Analysis 11.1.3. Market Estimation 11.1.4. Validation 11.1.5. Publishing 11.2. Research Attributes 11.3. Research Assumption List of Tables TABLE 1. Global Omics-Based Clinical Trials market, report scope TABLE 2. Global Omics-Based Clinical Trials market estimates & forecasts by Region 2019-2028 (USD Billion) TABLE 3. Global Omics-Based Clinical Trials market estimates & forecasts by Phase 2019-2028 (USD Billion) TABLE 4. Global Omics-Based Clinical Trials market estimates & forecasts by Study Design 2019-2028 (USD Billion) TABLE 5. Global Omics-Based Clinical Trials market estimates & forecasts by Indication 2019-2028 (USD Billion) TABLE 6. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 7. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 8. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 9. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 10. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 11. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 12. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 13. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 14. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion) TABLE 15. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion) TABLE 16. U.S. Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 17. U.S. Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 18. U.S. Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 19. Canada Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 20. Canada Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 21. Canada Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 22. UK Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 23. UK Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 24. UK Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 25. Germany Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 26. Germany Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 27. Germany Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 28. RoE Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 29. RoE Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 30. RoE Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 31. China Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 32. China Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 33. China Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 34. India Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 35. India Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 36. India Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 37. Japan Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 38. Japan Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 39. Japan Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 40. RoAPAC Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 41. RoAPAC Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 42. RoAPAC Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 43. Brazil Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 44. Brazil Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 45. Brazil Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 46. Mexico Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 47. Mexico Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 48. Mexico Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 49. RoLA Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 50. RoLA Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 51. RoLA Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 52. Row Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion) TABLE 53. Row Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 54. Row Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion) TABLE 55. List of secondary sources, used in the study of global Omics-Based Clinical Trials market TABLE 56. List of primary sources, used in the study of global Omics-Based Clinical Trials market TABLE 57. Years considered for the study TABLE 58. Exchange rates considered
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(薬学的薬物)の最新刊レポートBizwit Research & Consulting LLP社のその他分野での最新刊レポート
本レポートと同じKEY WORD(clinical trials)の最新刊レポートよくあるご質問Bizwit Research & Consulting LLP社はどのような調査会社ですか?Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|